Monoamine oxidase is an outer mitochondrial membrane protein that catalyzes the deamination of a number of neurotransmitters and dietary amines. To determine the roles of the carboxyl-terminal amino acids on the activity and solubility of human monoamine oxidase (MAO B), 10 sequential mutants were made with stop codons at amino acid positions 511, 504, 498, 492, 486, 481, 476, 467, 417, and 397, respectively. All truncated mutants were expressed in Sf21 insect cells using baculovirus, and the enzyme kinetic parameters were determined. Truncations at amino acid positions 511, 504, and 498 slightly decreased MAO B catalytic activity and had no significant changes on deprenyl inhibition. Further deletions up to amino acid 417 decreased the specific activity 10 -100-fold without significant changes of the K m for phenylethylamine or dopamine or the IC 50 for deprenyl and clorgyline. The truncation mutant C397, which lacks covalently attached FAD, was inactive. Progressive carboxylterminal truncations up to position 481 were correlated with increased solubility of MAO B mutants. 47% of the activity of the truncated C481 was found in the 105,000 ؋ g supernatant in the absence of detergent. However, further truncated mutants, C476, C467, and C417, remained associated with the membrane fraction. In contrast to crude homogenate, the water-soluble C481 mutant was rapidly inactivated at 4°C and 37°C, which indicates that the membrane environment is required for the stability of MAO B. Expression of the green fluorescent protein-MAO B C481 fusion protein revealed that this mutant was located in the cytoplasm, whereas its counterpart in MAO A, truncated mutant C490, was located on the mitochondria. These results suggest that the carboxyl-terminal amino acid residues 417-520 of MAO B are not directly involved in the active site but are required for maintaining the appropriate conformation and interaction with the outer mitochondrial membrane. The different solubilities of the various carboxyl-terminal truncation mutants indicate that the interaction of MAO B with mitochondrial membrane is not simply anchoring through the carboxylterminal hydrophobic tail. Further, our results suggest that the carboxyl-terminal of MAO A and B plays different roles in mitochondrial attachment.
Monoamine oxidase A and B (MAO 1 A and MAO B, EC 1.4.3.4) are flavoisoenzymes, which catalyze the oxidative deamination of neuroactive, vasoactive, and dietary amines (1) . MAO A and B are encoded by different genes (2) and have different substrate and inhibitor specificities (3, 4) . MAO A preferentially oxidizes serotonin (5-hydroxytryptamine) and is irreversibly inhibited by low concentrations of clorgyline. MAO B preferentially oxidizes phenylethylamine (PEA) and benzylamine, and it is irreversibly inactivated by low concentrations of pargyline and deprenyl. Dopamine, tyramine, and tryptamine are common substrates for both MAOs. MAO A and B consist of 527 and 520 amino acids, respectively, and have a 70% identity (2) . Each type of enzyme has a FAD covalently linked to a cysteine residue, Cys-406 in MAO A and Cys-397 in MAO B, through an 8␣-(S-cysteinyl)-riboflavin (5, 6) . MAO A and MAO B exhibit identical exon-intron organization, and they are probably derived from the duplication of a common ancestral gene (7) . The physiological role of MAO in neurotransmitter metabolism and its relation to behavior was recently reviewed (1, 8) .
MAO is an integral outer mitochondrial membrane protein (9) . MAOs lack the typical amino-terminal hydrophobic region flanked by the positively charged residues, which is common to a large group of outer mitochondrial anchored proteins (10) . Deletion of the 55 amino acids in the amino-terminal of the rat MAO B had no effect on the targeting and insertion into the outer mitochondrial membrane after expression in mammalian cells (11) . The mitochondrial anchoring of rat liver MAO B was shown to be within the carboxyl-terminal residues 492-520 by the fusion of this segment to a carboxyl terminus of cytochrome b5, which directed this chimeric protein to the outer mitochondrial membrane (11) . However, the truncation mutant of human MAO A lacking the putative membrane anchor (the last 24 carboxyl-terminal amino acid residues) was still found in the membrane fraction (12) . A particular importance of the carboxylterminal portions of MAOs for catalytic activity was demonstrated in a study of MAO A/MAO B chimeric proteins (13) . The partial model of MAO did not provide any information on the structural elements interacting with the outer mitochondrial membrane because of the lack of sufficient homology of MAO to proteins with known three-dimensional structure (14) . The structure of maize flavin-containing polyamine oxidase was recently solved (15) . This soluble enzyme has about 20% homology to MAO and lacks a corresponding carboxyl-terminal stretch of about 50 amino acids found in MAO. This further suggests a possible carboxyl-terminal anchoring of MAO to membrane.
In the last decade, MAO has been expressed in mammalian cell lines (16, 17) , yeast (18 -20) , and Escherichia coli (21, 22) . However, these expression systems have limitations including a low level of expression (mammalian cells and yeast), lack of covalently attached FAD, or proper folding of MAO (bacteria). In the present study, we report the solubilization and the purification of catalytically active MAO B expressed in baculovirus-infected insect cells. The advantages of this expression system for MAO are the simplicity and the efficiency of producing large quantities of enzyme needed for crystallization and structural studies.
We have studied the role of the carboxyl-terminal 123 amino acids of human MAO B by generating 10 sequential truncation mutants spanning amino acid positions 397-520. We constructed recombinant baculovirus, expressed the truncated mutants in insect cells, and analyzed the role of the carboxylterminal region on activity, solubility, and stability of this enzyme. Using specific and common substrates and inhibitors, we show that the carboxyl-terminal end is essential for interaction with the membrane but not directly involved in the active site of MAO B.
EXPERIMENTAL PROCEDURES
Materials-All chemicals (analytical grade) were obtained from Sigma. Insect cell culture media components were purchased from Invitrogen (San Diego, CA). Gentamycin, antibiotic-antimycotic, and fetal bovine serum were from Life Technologies, Inc. C8POE was from Bachem (Torrance, CA).
Construction of Baculovirus Transfer Vector-A cDNA clone encoding human MAO B (2) was subcloned into the EcoRI site of pVL1392 transfer vector (PharMingen, San Diego, CA) and named pVL1392-hMAOB. Proper orientation of the insert was verified by digesting the vector with restriction enzymes and sequencing. Recombinant MAO B encoding virus was produced by homologous recombination on the cotransfection of Sf21 cells with the vector and linearized baculovirus DNA (BaculoGold, PharMingen) using the calcium phosphate method. Recombinant baculovirus was isolated by plaque purification and amplified by infection of insect cells at a multiplicity of infection of one (MOI ϭ 1). After three to four passes, a viral stock with a titer of 10 8 plaque-forming units/ml was produced. Fusion constructs of GFP with MAO A and MAO B and their respective truncation mutants at position 481 (C481 for MAO B and C490 for MAO A) were prepared by subcloning the cDNA encoding human MAO isoenzymes in to EcoRI and KpnI restriction sites of the BioGreen pAcHTL-A plasmid (PharMingen).
Construction of Carboxyl-terminal Mutants-The single-or doublestop codons were introduced by site-directed mutagenesis at the positions indicated below directly into pVL1392-hMAOB. The QuikChange site-directed mutagenesis kit (Stratagene Cloning System, La Jolla, CA) was used with complimentary oligonucleotide primers. The following 5Ј-flanking primers were used for the reactions: C511 , CG GCT CTT  GGC TTC CTG TAA GAC AAA AGG GGG CTA C and G TAG CCC CCT  TTT GTG TTA CAG GAA GCC AAG AGC CG; C504, CC ACC ATC TTT  TCA TAA ACG GCT CTT GGC TTC C and G GAA GCC AAT AGC CGT  TTA TGA AAA GAT GGT GG; C498, 5Ј-G CTC AGG CTG ATT GGA  TAG ACC ACC ATC TTT TCA GC-3Ј and GC TGA AAA GAT GGT GGT  CTA TCC AAT CAG CCT GAG C; C492, 5Ј-G CCC TCC GTG CCA GGC  TAG CTC AGG CTG ATT GG-3Ј and 5Ј-CC AAT CAG CCT GAG CTA  GCC TGG CAC GGA GGG C-3Ј; C486, 5Ј-G GAG AGA CAT TAG CCC  TCC GTG CC-3Ј and 5Ј-GG CAC GGA GGG CTA ATG TCT CTC C-3Ј;  C481, 5Ј-CAG CCC ATC ACC ACC ACC TAA TAG GAG AGA CAT TTG  CCC TCC G-3Ј and 5Ј-C GGA GGG CAA ATG TCT CTC CTA TTA GGT  GGT GGT GAT GGG CGT-3Ј; C476, 5Ј-CT GTG GAT GTC CCT GCA  CAG TGA TAA ACC ACC ACC TTT TTG GAG AG-3Ј and 5Ј-CT CTC  CAA AAA GGT GGT GGT TTA TCA CTG TGC AGG GAC ATC CAC  AG-3Ј; C467, 5Ј-C TGG CAG TCA GAA TGA GAG TCT GTG GAT G-3Ј  and 5Ј-C ATC CAC AGA CTC TCA TTC TGA CTG CCA G-3Ј; C417,  5Ј-GG GTT CTA CGC CAG TGA GTG GAC AGG-3Ј and 5Ј-CCT GTC  CAC TCA CTG GCG TAG AAC CC-3Ј; and C397, 5Ј-G GAG CAG TAC  TCT GGG GGC TGA TAG ACA ACT TAT TTC CCC CCT GGG-3Ј and  5Ј-CCC AGG GGG GAA ATA AGT TGT CTA TCA GCC CCC AGA GTA  CTG virus stock at MOI ϭ 1. Cells were harvested 75-80 h post-infection by centrifugation at 10,000 ϫ g for 10 min. The cell pellet was washed once with Tris-buffered saline (TBS) to remove serum proteins from the growth medium. After resuspending Sf21 cells in homogenization buffer (20 mM phosphate buffer, pH 7.4, containing 250 mM sucrose and 0.5 mM phenylmethylsulfonyl fluoride), the cells were lysed in a glass/ Teflon loose fitting homogenizer. Mitochondria were isolated by centrifugation of homogenate between 1,000 ϫ g for 5 min and 20,000 ϫ g for 20 min and washed twice. 85% of the original MAO B activity was found in crude homogenate, which can be stored several months at Ϫ80°C without any loss of activity.
MAO B Activity Assay-Enzyme activity was determined radiochemically using [ 14 C]PEA as substrate (6) . When dopamine was used as the substrate, the reaction products were separated and quantified by HPLC with electrochemical detection.
In a typical dopamine assay, the reaction is carried out in 50 mM sodium phosphate buffer, pH 7.4, at 37°C for 20 min. The assay mixture contained enzyme preparation, and the reaction was started by the addition of dopamine (0.5-2.0 mM final concentration, depending on K m ) in a total volume of 200 l. The conversion of 3,4-dihydroxyphenylaldehyde to 3,4-dihydroxyphenylacetic acid (DOPAC) was carried out by adding to the reaction mixture 1 unit of yeast aldehyde dehydrogenase, NAD (5 mM), dithiothreitol (50 nM), and nicotinamide (5 M). The reaction was terminated by the addition of 200 l of ice-cold solution of 0.2 N perchloric acid containing 10 mM sodium metabisulfite and 5 mM EDTA. After mixing with a Vortex, the mixture was centrifuged at 12,500 ϫ g for 15 min. The supernatant was diluted with an equal volume of HPLC mobile phase containing 1 M isoproterenol as an internal standard. HPLC separation of dopamine assay mixture was performed at ambient room temperature on a 150 ϫ 4.6-mm reverse phase analytical column packed with C-18 spherical 3-m particles (Luna II, Phenomenex). A 4 ϫ 3-mm C18 guard cartridge was installed between the Shimadzu automated sample injector and the analytical column. A 50-l aliquot of the prepared sample was injected onto the column. The mobile phase contained 75 mM monobasic sodium phosphate buffer, pH 2.8, 1 mM sodium octyl sulfate, 0.5 mM EDTA, and 13.5% (v/v) acetonitrile. The column flow rate was 1 ml/min. The electrochemical detector was set at ϩ0.7 V. The signal from the detector was integrated by peak area using Class VP software (Shimadzu). Standards of dopamine and DOPAC were injected onto the column for calculation of an unknown amount of reaction product.
The inhibitory effects of deprenyl and clorgyline on the activity of MAO B and carboxyl-terminal truncation mutants were estimated by using [ 14 C]PEA as substrate. The enzyme preparations were preincubated in the presence of various concentrations of inhibitors for 15 min at 37°C prior to the determination of activity. All catalytic measurements were carried out in triplicates, and mean values are shown; all standard errors of the mean (S.E.) were less than 5-10%. (23) with modifications (24). Whole cell homogenates or proteins at various stages of purification were denatured by boiling for 5 min in sample buffer (60 mM Tris/HCl buffer, pH 6.8, containing 2% (w/v) SDS, 100 mM dithiothreitol, 10% (v/v) glycerin, and 0.1% (w/v) bromphenol blue. The samples were subjected to 0.75-mm gels consisted of 4% stacking and 10% separating gels using Bio-Rad Miniprotean gel apparatus. The separation was carried out at constant current at 30 V for stacking gels and at 100 V for separating gels.
SDS Gel Electrophoresis and Western Blotting-SDS-polyacrylamide gel electrophoresis was carried out according to the method of Laemmli
Electrotransfer of proteins to nitrocellulose membrane (Bio-Rad) was carried out at 4°C in transfer buffer containing 15.6 mM Tris base, 100 mM glycine, and 15%(v/v) methanol at constant current of 120 V for 90 min. Immunodetection of MAO B was performed at ambient room temperature. Nitrocellulose membrane was incubated with blocking buffer containing 3% (w/v) bovine serum albumin and 0.05% (v/v) Tween 20 in TBS (10 mM Tris/Cl buffer, pH 7.5, and 150 mM NaCl) for 2 h. Nitrocellulose membrane was washed three times for 10 min in TBS and incubated with rabbit anti-MAO B serum ( Fig. 2 . Baculovirusmediated expression in insect cells resulted in the appearance of a major band with a M r of 60 kDa compared with mockinfected cells on the SDS gel. The MAO B band was found to represent up to 25% of total protein in membrane preparations. The mitochondrial pellet was resuspended in 250 ml of 25 mM sodium phosphate buffer, pH 6.8, and MAO B was extracted by the addition of C8POE in four steps using increasing detergent concentrations (5.0, 7.0, 15.0, and 17.5 mM). After incubating for 1 h at room temperature on a rotary shaker, mixtures were centrifuged for 1 h at 105,000 ϫ g. Most of the MAO B (45% yield by activity) was recovered in the soluble S100 supernatant of extracts containing 15 and 17.5 mM C8POE. Extraction at lower concentrations of detergent (5.0 and 7.0 mM, which are slightly below the critical micellar concentration) was not sufficient to solubilize the MAO B but was beneficial for removing impurities, which interfere with further purification by absorption chromatography. Increasing the detergent to a higher concentration than 17.5 mM during solubilization did not lead to an increase in solubility; instead it inhibited enzyme activity. Solubilized MAO B was mixed with 100 ml of 50% (v/v) suspension of hydroxyapatite (Biogel HT, Bio-Rad) equilibrated with 25 mM sodium phosphate, pH 6.8, containing 10 mM C8POE. This mixture was incubated for 2 h at 4°C and resuspended four to five times during this incubation. Hydroxyapatite was collected by low speed centrifugation (5 min at 1,000 ϫ g), and after washing with equal volumes of absorption buffer, the protein was eluted with phosphate buffer containing 10 mM C8POE by a stepwise increase in the concentration of the phosphate buffer (100, 200, 300, and 400 mM). Fractions at 100 and 150 mM phosphate buffer (end concentration) containing the bulk of MAO B activity (27% overall yield) were combined, and the buffer was exchanged to 5 mM sodium phosphate buffer, pH 7.4, containing 10 mM C8POE by concentration in Amicon pressurized cells using YM-100 membrane. Concentrated MAO B with a protein concentration of up to 15 mg/ml was stored at Ϫ80°C after the addition of 50% (v/v) glycerol to prevent aggregation. The purity of the final preparation was more than 95% in SDS-polyacrylamide gel electrophoresis analysis (Fig. 2) . The typical yield from 5 liters of Sf21 insect cell culture was 10 -15 mg of electrophoretically homogeneous MAO B.
RESULTS

Expression and Purification of Human MAO B-Expression of MAO B in Sf21 insect cells is shown in
Expression of Carboxyl-terminal Truncation MutantsSmall scale expression was conducted in an adherent cell culture of Sf21 cells at MOI ϭ 2 for all carboxyl-terminal truncation mutants and full-length wild type MAO B. At 75 h post-infection with recombinant baculovirus, cells were harvested, washed, and lysed with several strokes in glass/Teflon homogenizer in 50 mM sodium phosphate buffer, pH 7.4. Crude cell homogenates were used for activity assays and electrophoretic analysis. Specific activities of carboxyl-terminal truncated mutant proteins compared with wild type MAO B are shown in Fig. 3A . There was a slight decrease in specific activity for C511, C504, and C498 and a large decrease (Ͼ10-fold) for the C492, C486, C481, C476, C467, and C417 mutants. C397 mutant protein lacking covalently attached FAD was completely inactive despite the fact that the protein was expressed to the same level as wild type MAO B. The level of expression for all mutant proteins was approximately the same as full-length wild type MAO B as demonstrated by immunoblot analysis using polyclonal anti-human MAO B antibody (Fig. 3B) . There was no difference in expression patterns between carboxyl-terminal truncated mutants containing one (C511, C504, C498, C492, C486, C467, and C417) or two stop codons (C481, C476, and C397). A stepwise gradual decrease of the molecular weight of the MAO B band was correlated with the progression of truncations. No trace of full-length MAO B could be detected in cell homogenates of carboxyl-terminal truncated mutants by Western blot analysis.
Kinetic Characterization of Carboxyl-terminal Truncation Mutants- Table I summarizes the results of catalytic characterization of MAO B and its carboxyl-terminal truncated mutant proteins using PEA and dopamine as specific and common substrates, respectively. The effects of irreversible MAO inhibitors, deprenyl and clorgyline, were also studied. A slight decrease in V max for PEA (4-fold) and dopamine (2-fold) was found in carboxyl-terminal truncated mutants up to position 498. Further truncations of MAO B lead to a 10 -100-fold drop in V max values. A larger decrease in V max was observed with PEA, a MAO B-specific substrate, when compared with dopamine, the common substrate for both types of MAO. The decrease in V max , however, was not associated with changes in K m , which were almost the same for all carboxyl-terminal truncated mutant proteins as for the full-length MAO B. On the other hand, a gradual increase in K m for dopamine was observed with progression of truncations up to position 476. The C481 and C476 mutant proteins have 5-6-fold increases in K m for dopamine compared with the full-length enzyme. Further truncation mutants (C467 and C417) displayed K m values for dopamine 1.5-2.0 times higher than those of nontruncated MAO B. Similarly, an increase in IC 50 for deprenyl and clorgyline was observed in inhibition experiments with carboxyl-terminal truncation mutants up to position C476 (Table I) .
Solubility of Carboxyl-terminal Truncation Mutant Proteins-Homogenates of Sf21 insect cells after the expression of MAO B and carboxyl-terminal truncated mutants were subjected to ultracentrifugation at 105,000 ϫ g for 60 min. The pellets were resuspended in the same volume as the original homogenate. MAO B activity in homogenate, S100 supernatant, and pellet samples was measured using dopamine as substrate. The activities of MAO B retained in S100 extracts are summarized in Fig. 4A . The full-length MAO B and C511, C504, and C498 mutant proteins were in pellets after ultracentrifugation as demonstrated by the lack of significant activity found in the S100 fraction. The carboxyl-terminal truncated mutants C492, C486, and C481 show increased activity in the S100 soluble fraction: 10.1, 22,3, and 47.8% of activity in crude homogenates, respectively. However, significant activities of the truncation mutants C476, C467, and C417 were found again in the membrane fraction. The retention of the C481 truncated protein in S100 extract was further analyzed by gel electrophoresis and immunoblotting (Fig. 4B) . Full-length MAO B was tightly associated with the membrane fraction, whereas the C481 protein after ultracentrifugation was found distributed evenly in the S100 extract and membrane fraction.
The Stability of C481 Mutant Protein- Fig. 5 shows the decrease of activity of the C481 mutant protein during incubations at both 4°C and 37°C. The C481 mutant was totally inactivated after 30 h of incubation at 4°C in contrast to full-length wild type MAO B (Fig. 5A) . The stability of the C481 mutant retained in 105,000 ϫ g soluble fraction was compared with the homogenate at 37°C during the standard dopamine activity assay (Fig. 5B) . After mixing the enzyme and substrate, the aliquots were removed from the reaction mixture and analyzed by HPLC with electrochemical detection for product (DOPAC) formation. In contrast to the linear formation of DOPAC found for the C481 protein in crude homogenate, there was a rapid decay in DOPAC formation in the soluble fraction. Depletion of DOPAC was observed after 15 min of the reaction at 37°C. The same inactivation was found also for C486 mutant protein extracted into the S100 soluble fraction; however, 13) and truncated mutants C397, C417, C467, C476, C481, C486, C492, C498, C504, and C511 (lanes 3-12, respectively). Lane 2 is the negative control of mock-infected insect cells. 500 ng of crude homogenates were separated by SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose, and probed with polyclonal anti-MAO B antibody as described under "Experimental Procedures." the inactivation rates were about four times slower than those found for the C481 mutants (data not shown). The stability of the C481 mutant could not be improved by varying pH and ionic strength and by the addition of different detergents. When more than 25% glycerin (v/v) was added to the protein solution, it slowed down the inactivation but could not stop completely this process.
Expression and Characterization of GFP-MAO Fusion Proteins-To assess the intracellular localization of the C481 mutant and compare the effect of this truncation on the properties of MAO B versus MAO A, we constructed fusion proteins of full-length and C481 truncated MAOs containing GFP at the amino terminus. After the isolation of recombinant baculovirus, fusion proteins were expressed at MOI ϭ 1. Live insect cells were labeled with the specific mitochondrial fluorescent marker MitoTracker Red and analyzed by fluorescent microscopy (Fig. 6) . GFP-MAO B fusion protein was found to be expressed in the mitochondria as shown by co-localization of green and red fluorescence corresponding to GFP and Mito- 
FIG. 4. The solubility of MAO B and its carboxyl-terminal truncation mutants in the absence of detergents.
A, activity of carboxyl-terminal truncated mutants and wild type MAO B retained in the soluble S100 fraction (fract) after ultracentrifugation of cell homogenates at 105,000 ϫ g for 60 min. Mean values from three experiments are shown on the top of the bars. B, Western blot analysis of the equal aliquots (10 l) of crude homogenate (H), supernatant after 105,000 ϫ g centrifugation (S100 soluble fraction), and membrane fraction (P, resuspended pellet after ultracentrifugation) of the full-length wild type MAO B, the C481 truncation mutant, and mock-infected Sf21 cells.
FIG. 5.
Thermal stability of C481 mutant in homogenate and soluble S100 fraction. A, stability at 4°C. The homogenates (filled circles) and S100 extracts (open circles) were incubated at 4°C for 1, 2, 4, 8, 18, and 30 h and then MAO B activity was determined using dopamine as substrate. B, stability of the C481 truncation mutant of MAO B in homogenate (filled circles) and S100 extract (open circles) during standard assay conditions except with increasing incubation time. The samples containing the C481 mutant (homogenate or S100 extract) were incubated in 50 mM sodium phosphate buffer, pH 7.4, at 37°C with 1 mM dopamine as substrate. After 5, 10, 15, 25, 45 , and 60 min of incubation, aliquots were removed, and the reaction was stopped by mixing with equal volume of 0.2 N perchloric acid. The amount of DOPAC formed in each reaction was determined by HPLC with electrochemical detection as described under "Experimental Procedures."
Tracker Red, respectively. In contrast, cells expressing the GFP-C481 fusion protein have green fluorescence throughout the cell body characteristic for the distribution of protein in cytoplasm as it was found for expression of GFP alone. Relocalization of the GFP-MAO B(C417) mutant to the mitochondria was also confirmed after staining the live insect cells expressing this mutant fusion protein with MitoTracker Red and fluorescence analysis using the triple filter system for simultaneous view of the GFP and MitoTracker Red specific fluorescence (Fig. 6) . This confirmed the distribution of the activity of the shortest carboxyl-terminal truncation mutants in the membrane fraction found in a previous experiment (Fig. 4) .
The properties of the C481 truncated mutant compared with full-length enzymes are summarized in Table II . The corresponding carboxyl-terminal truncated mutant of MAO A (GFP-MAO A(C490) mutant) was found to be inactive, and the fusion protein was targeted to the mitochondria. 44% of the activity of the GFP-MAO B(C481) mutant was retained in a soluble S100 fraction after ultracentrifugation at 105,000 ϫ g for 60 min.
DISCUSSION
It has been proposed that the carboxyl-terminal 30-amino acid residues of mitochondrial MAO contribute to the targeting and membrane anchoring of this enzyme to the outer mitochondrial membrane. In one study, truncation of rat MAO B at position 492 resulted in the cytosolic expression of this mutant protein, and a chimeric construct of the soluble cytochrome b5 fused with the 492-520 peptide of rat MAO B was targeted to the mitochondria in COS-1 cells (11) . The analysis of distribution of MAO was carried out, however, by immunodetection of MAO B protein because of nondetectable activity for this truncation mutant. In another study, truncation of the 24 carboxylterminal residues of human MAO A did not change the outer mitochondrial localization of this mutant protein after its expression in yeast (12) . Lack of carboxyl-terminal structural homology of trout mitochondrial MAO to mammalian enzymes may indicate an involvement of other regions in membrane targeting and insertion (25) . The recent interest in the structural basis of the interaction of MAO with the outer mitochondrial membrane triggered our attempt to construct a water-soluble form of the MAO B protein by gradual truncations of the carboxyl-terminal end, the anticipated putative membrane anchor. The expression of such an enzyme, which does not require detergents for extraction and purification, would be beneficial for the crystallization of MAO, which has so far proven to be difficult.
The present study used for the first time baculovirus-mediated expression of human MAO in insect cells to extend these earlier suggestions and investigate the effects of further truncations on the enzyme kinetic parameters, solubility and intra- b Solubility represents percentage of activity retained in soluble S100 fraction after ultracentrifugation of homogenates for 60 min at 105,000 ϫ g.
TABLE II Characteristics of carboxyl-terminal truncated mutants GFP-MAO A (C490) and GFP-MAO B (C481) fusion proteins
c Localization of fusion proteins in the Sf21 cells determined by GFP fluorescence as shown in Fig. 6 . d omm, outer mitochondrial membrane. e ND, not determined. cellular localization. The combination of efficient expression of human MAO B in insect cells, extraction with the nonionic detergent C8POE, and absorption chromatography allowed us to purify milligram quantities of homogeneous active protein.
Active truncation mutants up to position 417 were expressed along with full-length MAO B in insect cells using recombinant baculovirus. Mutant C397 was expressed to the same level as the full-length enzyme and was completely inactive. This observation is inconsistent with the report by Hiro et al. (20) that the replacement of Cys for Ala in rat MAO A, which abolishes the covalent attachment of FAD, was not essential for catalytic activity and/or substrate binding, but it is in agreement with the result of Wu et al. (6) in which a C397A mutation abolished enzyme activity. The absence of measurable activity of C397 mutant suggests that flavin was not incorporated in this protein. The complete loss of FAD integration in C397 mutant could be an indication of the essential role of the carboxylterminal portion 397-417 of MAO B for the structural support of the FAD docking because the C417 mutant was active and displayed K m and IC 50 values similar to those of the full-length enzyme. A high level of expression of active carboxyl-terminal truncation mutants of human MAO B provides us with the opportunity to characterize the role of 123 carboxyl-terminal amino acid residues on the catalytic properties of this enzyme. This is in contrast to the report by Mitoma and Ito (11) in which the catalytic characterization of carboxyl-terminal truncation mutants of rat MAO B could not be carried out because of nondetectable activity. The decrease of V max correlated with the progression of truncation up to position 417 was observed with the specific MAO B substrate PEA as well as with dopamine, a common substrate for MAO A and MAO B. The V max decrease for PEA was completely independent from the changes in K m , which were the same for most carboxyl-terminal truncation mutant proteins. The decrease in V max for dopamine was similar to those for PEA except for the extent, which was slightly less than for PEA. The K m values for dopamine increased by about 6-fold for C481 and C476; however, further truncations showed K m values again close to full-length wild type MAO B.
The IC 50 of the MAO B-and MAO A-specific irreversible inhibitors deprenyl and clorgyline, respectively, revealed only minor changes in most mutants (about 1.5-2.0-fold). The largest changes, however, were found for C481 and C476 mutant proteins (up to 5-fold). This increase in K m for dopamine and in IC 50 for deprenyl and clorgyline for the C481 and C476 mutants can be attributable to conformation changes in MAO B upon the removal of a hydrophobic stretch within amino acid segment 481-520. The retaining of binding properties toward specific and nonspecific substrates and inhibitors by carboxylterminal truncation mutant proteins indicates that this carboxyl-terminal portion of MAO B is not contributing crucial residue(s) that are part of the enzyme active site. Moreover, the decrease in the reaction rates by 1-2 orders of magnitude for the shortest active carboxyl-terminal truncation proteins compared with full-length MAO B is also unlikely to be attributable to the removal of amino acid(s) participating in catalysis. For example, the C397 mutant lacking covalently attached FAD was completely inactive in our assay conditions, which would allow us to detect enzyme activity 4 -5 orders of magnitude lower then those of the wild type MAO B. The decrease of V max values found in carboxyl-terminal truncation mutants more likely reflects some perturbations of the structure of MAO upon the removal of large carboxyl-terminal portions of the protein, which plays an important role in the interaction with the outer mitochondrial membrane. The fact that the most soluble carboxyl-terminal truncation mutant C481 became very unstable after separation from the membrane fraction provides an additional indication of the crucial contribution of the membrane environment to the structural integrity of native MAO. Similar conclusions were drawn from the study on MAO A after the truncation of the 24 carboxyl-terminal amino acid residues (12) . We have also constructed a mutant of human MAO A truncated at position 481. However, analysis of this protein reveals complete loss of catalytic activity and unchanged mitochondrial localization after expression of GFP-MAO A(C490) fusion protein in Sf21 insect cells. The different impact of truncations at this position on the catalytic properties of MAO A and MAO B mutant proteins and their different intracellular targeting suggest that the structural elements of MAO A and B involved in the interaction with the outer mitochondrial membrane are not the same but rather unique for each isoenzyme. The loss of activity of MAO A but not MAO B after truncation at position 481 points toward a crucial role of the carboxylterminal region for the catalytic activity of MAO A but not MAO B. This is in good agreement with previous work on the characterization of chimeric human MAO A/B enzymes (13). Chen et al. (13) have shown that replacing 128 amino acids from the carboxyl terminus of MAO B by the corresponding 126 amino acids from the carboxyl terminus of MAO A results in nondetectable activity for the chimeric enzyme. The chimeric enzyme with reverse replacement of the carboxyl terminus, however, exhibited enzymatic properties similar to MAO A.
The effect of truncations on the solubility of MAO B was found to be correlated with the carboxyl-terminal 36-amino acid segment (
. This segment contains three highly hydrophobic regions, which are intervened by positively charged amino acids (See Fig. 1 for details) . Our results indicate that only complete removal of this region results in maximal solubility, which was 47% for the C481 mutant. Surprisingly, truncations beyond position 481 resulted in the association of shorter carboxyl-terminal truncation mutant proteins (C476, C467, and C417) with the membrane again. The reverse localization of MAO B from partially soluble (C481)) to membrane bound (C476, C467, and C417) was shown by analysis of the distribution of MAO activity between soluble and membrane fractions as well as co-localization of the fluorescence of GFP-MAO fusion proteins with specific mitochondrial staining.
This suggests that the interaction of MAO B with the outer mitochondrial membrane is more complex than the anchoring through the carboxyl-terminal 36-amino acid anchor. Increased solubility of the C481 mutant as a result of different intracellular localization was also demonstrated after expression of the GFP-MAO B(C481) fusion protein. The distribution of fluorescence of this fusion protein through the cytoplasm of the cell in addition to mitochondria indicates that at least half of the expressed protein was not inserted into the outer mitochondrial membrane. The fusion of the water-soluble GFP protein to the amino-terminal end of the C481 mutant of MAO B, however, has not improved the solubility or the stability of this protein when compared with the C481 mutant alone. A more extensive search of conditions preventing the inactivation of C481, the soluble truncation mutant of MAO B, would be necessary to attempt the large scale purification of this protein for crystallization trials. The deletion of the six amino acids 476 -481 (PITTF, see Fig. 1 for details) in MAO B was found to reverse the intracellular localization of the protein from soluble C481 back to mitochondrial C476 (and also C467 and C417). This is striking. It indicates the importance of this region in the MAO B sequence for the activity and localization of this enzyme. The future experiments on the internal deletions of these amino acids from the full length of protein will be useful to determine whether this region represents a critical internal sorting motif for MAO.
The variations of the solubility behavior of different carboxyl-terminal truncation mutants of human MAO B can be explained as follows; however, clear proof will require further experimental approaches and especially determination of the three-dimensional structure of this membrane protein. Large truncations, such as the removal of up to 24% of the protein as we demonstrated in the present work, can expose the inner hydrophobic region(s) of MAO B contributing to the nonspecific interaction of the carboxyl-terminal truncation mutant proteins with the mitochondrial membrane. The sequence of MAO B contains seven hydrophobic regions (2) , which can be potentially responsible for interactions with membranes. Segments V (345-355) and VII (485-520) are surrounded by clusters of positively charged amino acids, whereas segments III (170 -200) and IV (265-315) contain two and three consecutive positively charged amino acids on one end, respectively, as shown in Fig. 1 . These segments have structural similarity (stretches of hydrophobic amino acids flanked by positively charged ones) to the 22-amino acid carboxyl-terminal transmembrane domain of Bcl-2 (K ϩ TLLSLALVGACITLGAYLGH ϩ K ϩ ), which has been shown to direct the insertion of this protein into the outer mitochondrial membrane (26) . The different lengths of the above mentioned segments of MAO may indicate that this region more likely represents a ␤-barrel structure rather than the predicted bi-layer spanning ␣-helix of 20 -22 amino acids as in the case of Bcl-2 (10). The regions III, IV, and V therefore could be recognized by mitochondrial membrane import machinery after the removal of the proximal carboxyl-terminal portion of MAO B (regions VI and VII). It was suggested earlier that the absence of the 29 carboxyl-terminal amino acids in the "shortest" MAO from trout, which has 499 amino acids that are also located on the mitochondria, is not sufficient to make this protein soluble nor to change the intracellular localization (25) . The interaction of MAO B with the outer mitochondrial membrane may also occur through multiple segments of the protein, some of them inserted into the membrane and others only interacting with it. The hexameric (trimer of dimers) globular form of bovine liver MAO B observed in electron microscopic studies (27) support the last hypothesis, indicating that a considerable portion of the MAO B protein can be in contact with the mitochondrial membrane.
In conclusion, this study suggests that 1) the carboxyl-terminal amino acid residues 417-520 are not directly involved in the active site, 2) truncation of 39 carboxyl-terminal amino acids results in partially soluble enzyme that catalytically active, and 3) other region(s) of this protein in addition to the carboxyl-terminal domain of MAO B may interact with the outer mitochondrial membrane. Experimental verification of such regions by means of internal deletions will further facilitate the structure-function characterization of this membrane protein.
